Abstract

Ovarian Hyperstimulation Syndrome (OHSS) is a spectrum of clinical features typically resulting from assisted conception techniques. With 2.35% of all live births in the UK resulting from in-vitro fertilisation (IVF), OHSS is on the rise. Moreover, there has been an increase in the presentation of its complications to GP surgeries and unscheduled acute care services nationwide. This review will discuss signs and symptoms of the increasingly common and potentially fatal complications of OHSS, namely pleural effusion, ascites and thromboembolic events. With such propensity toward critical, life-threatening events it is not only prudent to recognise the population at risk, but also to be aware of the signs, symptoms and complications to expedite treatment and ensure optimum outcome.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Zivi E, Simon A, Laufer N. Ovarian Hyperstimulation Syndrome: Definition, Incidence, and Classification. Seminars in Reproductive Medicine. 2010; 28(6): 441–7.
2. Calabro RS, Gervasi G, Leo A, et al. Neurovascular complications of ovarian hyperstimulation syndrome (OHSS): from pathophysiology to recent treatment options. Recent patents on endocrine, metabolic & immune drug discovery. 2014; 8(2): 109–16.
3. Marcus. Risks and Complications of IVF Treatment. [updated May 201317 September 2014]. Available from: http://www.ivfinfertility.com/ivf/standard/complications/ovarian_stimulation/ohss.php.
4. Madill JJ, Mullen NB, Harrison BP. Ovarian Hyperstimulation Syndrome: A potentially fatal complication of early pregnancy. Journal of Emergency Medicine. 2008; 35(3): 283–6.
5. Nelson SM. Venous thrombosis during assisted reproduction: Novel risk reduction strategies. Thrombosis research. 2013; 131: S1–S3.
6. Baron K, Babagbemi K, Arleo E, et al. Emergent Complications of Assisted Reproduction: Expecting the Unexpected. RadioGraphics. 2013; 33(1): 229–44.
7. Statistics OfN. Births in Engalnd and Wales, 2012. 2013.
8. Authority HFaE. Latest UK IVF figures: 2010 and 2011. [30 August 2014]. Available from: http://www.hfea.gov.uk/ivffigures-2006.html.
9. Shifman EM, Pogodin OK, Gumeniuk EG, et al. [Intensive care for ovarian hyperstimulation syndrome]. Anesteziologiia ireanimatologiia. 2007 (4): 77–81.
10. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot. Journal of Thrombosis and Haemostasis. 2006; 4(8): 1673–7.
11. Alper MM, Smith LP, Sills ES. Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. Journal of experimental & clinical assisted reproduction. 2009; 6: 3.
12. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003; 9(1): 77–96.
13. Dulitzky M, Cohen SB, Inbal A, et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertility and sterility. 2002; 77(3): 463–7.
14. Frasure SE, Rempell JS, Noble VE, et al. Emergency ultrasound diagnosis of ovarian hyperstimulation syndrome: case report. The Journal of emergency medicine. 2012; 43(2): e129–32.
15. Vloeberghs V, Peeraer K, Pexsters A, et al. Ovarian hyperstimulation syndrome and complications of ART. Best Practice & Research Clinical Obstetrics & Gynaecology. 2009; 23(5): 691–709.
16. Kumar P, Sait SF, Sharma A, et al. Ovarian hyperstimulation syndrome. Journal of human reproductive sciences. 2011; 4(2): 70–5.
17. Miller MA, Wirtz E, Pease J. An unusual cause of tachycardia, hypotension, and intraabdominal free fluid: ovarian hyperstimulation syndrome. The American journal of emergency medicine. 2008; 26(6): 736.e3–4.
18. Gynaecologists RCoOa. The Management of Ovarian Hyperstimulation Syndrome. London: RCOG; 2006.
19. Mullin CM, Fino ME, Reh A, et al. Symptomatic Isolated Pleural Effusion as an Atypical Presentation of Ovarian Hyperstimulation Syndrome. Case Reports in Obstetrics and Gynecology. 2011; 2011: 4.
20. Abuzeid M, Warda H, Joseph S, et al. Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter. Facts, views & vision in ObGyn. 2014; 6(1): 31–7.
21. Ozgun MT, Batukan C, Oner G, et al. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2008; 24(11): 656–8.
22. Murdoch AP, Evbuomwan I. Severe complications of ovarian hyperstimulation syndrome are preventable. Human reproduction. 1999; 14(11): 2922–3.
23. Alasiri SA, Case AM. Thrombosis of subclavian and internal jugular veins following severe ovarian hyperstimulation syndrome: a case report. Journal of obstetrics and gynaecology Canada: JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC. 2008; 30(7): 590–7.
24. Shmorgun D, Claman P. Joint Society of Obstetricians and Gynaecologists of C-C, Fertility Andrology Society Clinical Practice Guidelines C, Reproductive Endocrinology and Infertility Committee of the S, Executive and Council of the Society of O, et al. The diagnosis and management of ovarian hyperstimulation syndrome. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC. 2011; 33(11): 1156–62.
25. Yildizhan R, Adali E, Kolusari A, et al. Ovarian Hyperstimulation Syndrome with pleural effusion: a case report. Cases journal. 2008; 1(1): 323–.
26. Levin I, Almog B, Avni A, et al. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertility and sterility. 2002; 77(5): 986–8.
27. Maslovitz S, Jaffa A, Eytan O, et al. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstetrics and gynecology. 2004; 104(2): 321–6.
28. Junqueira JJ, Bammann RH, Terra RM, et al. Pleural effusion following ovarian hyperstimulation. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2012; 38(3): 400–3.
29. Grossman LC, Michalakis KG, Browne H, et al. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertility and sterility. 2010; 94(4):1392-8.
30. Sukul SP, Pekelharing JE, van Hooff MH, et al. [Thrombosis in ovarian hyperstimulation syndrome]. Nederlands tijdschrift voor geneeskunde. 2014; 158: A7108.
31. Hansen AT, Kesmodel US, Juul S, et al. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Human reproduction. 2014; 29(3): 611–7.
32. Endo T, Honnma H, Hayashi T, et al. Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos. Human reproduction. 2002; 17(10): 2548–51.
33. Bar-On S, Cohen A, Levin I, et al. [Upper extremity deep vein thrombosis following ovarian stimulation]. Harefuah. 2011; 150(11): 849–51, 75.
34. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertility and sterility. 2012; 97(1): 95–100.
35. Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC. 2014; 36(6): 527–53.
36. Nelson SM, Greer IA. Artificial reproductive technology and the risk of venous thromboembolic disease. Journal of thrombosis and haemostasis : JTH. 2006; 4(8): 1661–3.
37. Kasum M, Danolic D, Oreskovic S, et al. Thrombosis following ovarian hyperstimulation syndrome. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 2014; 30(11): 764–8.
38. Jozwik M. The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome. Medycyna wieku rozwojowego. 2012; 16(4): 269–71.
39. Fox NS, Laughon SK, Bender SD, et al. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstetrics and gynecology. 2008; 112(4): 884–9.
40. Gynaecologists RCoOa. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. 2009.
41. Rao AK, Chitkara U, Milki AA. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Human reproduction. 2005; 20(12): 3307–12.
42. Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Current opinion in obstetrics & gynecology. 2009; 21(3): 207–18.
43. Serdynska-Szuster M, Jedrzejczak P, Ozegowska K, et al. Perinatal outcome among women undergoing in vitro fertilization procedures complicated by ovarian hyperstimulation syndrome. Ginekologia Polska. 2012; 83(2): 104–10.
44. Patel SJ, Reede DL, Katz DS, et al. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007; 27(6): 1705–22.
45. Groves AM, Yates SJ, Win T, et al. CT pulmonary angiography versus ventilation-perfusion scintigraphy in pregnancy: Implications from a UK survey of doctors’ knowledge of radiation exposure. Radiology. 2006; 240(3): 765–70.
46. Hurwitz LM, Yoshizumi T, Reiman RE, et al. Radiation dose to the fetus from body MDCT during early gestation. American Journal of Roentgenology. 2006; 186(3): 871–6.
47. Winer-Muram HT, Boone JM, Brown HL, et al. Pulmonary embolism in pregnant patients: Fetal radiation dose with helical CT. Radiology. 2002; 224(2): 487–92.
48. Parker MS, Hui FK, Camacho MA, et al. Female breast radiation exposure during CT pulmonary angiography. American Journal of Roentgenology. 2005; 185(5):1228–33.
49. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. European radiology. 2005; 15(6): 1234–40.